Sinuote Bio-Tech

Sinuote Biopharmaceutical is a clinical-stage biotechnology company based in Beijing, China, specializing in the development of high-end inhalation therapies for respiratory conditions. The company focuses on addressing the high technical barriers associated with pulmonary drug delivery, developing both innovative drug combinations and complex generics for Chronic Obstructive Pulmonary Disease (COPD) and asthma. Its lead pipeline candidates, such as SN001 and SN011, are in late-stage clinical development and target multi-billion dollar markets currently dominated by global pharmaceutical giants. Sinuote integrates drug formulation with proprietary device design to ensure precise dosing and improved patient outcomes. Supported by leading venture capital firms, the company is expanding its manufacturing capabilities to support commercial-scale production.